1-4 of 4
Ulrich Duenzinger
Close
Sort by
Journal Articles

Early Disease Progression Predicts Poorer Survival in Patients with Follicular Lymphoma (FL) in the GALLIUM Study

Aino Launonen, Wolfgang Hiddemann, MD PhD, Ulrich Duenzinger, Günter Fingerle-Rowson, Tina Nielsen, Robert Marcus
Journal: Blood
Blood (2017) 130 (Supplement 1): 1490.
https://doi.org/10.1182/blood.V130.Suppl_1.1490.1490
Published: 2017
Journal Articles

Post-Transplant Maintenance With The Deacetylase Inhibitor Panobinostat In Patients With High-Risk AML Or MDS: Results Of The Phase I Part Of The Panobest Trial

Gesine Bug, MD, PhD, Andreas Burchert, MD, Kroeger Nicolaus, MD, Sabine Huenecke, PhD, Ulrich Duenzinger, MD, Andrea Wolf, Peter Bader, Hubert Serve, MD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2013) 122 (21): 3315.
https://doi.org/10.1182/blood.V122.21.3315.3315
Published: 2013
Journal Articles

Long-Term Results of a Fast Transplant Versus a Classical Conditioning Strategy for Allogeneic Stem Cell Transplantation of High Risk Acute Myeloid Leukemia (AML) Patients

Ulrich Duenzinger, Hans Martin, Sabine Mousset, Salem Agip, Stefan A. Klein, MD, Hubert Serve, Gesine Bug
Journal: Blood
Blood (2010) 116 (21): 1336.
https://doi.org/10.1182/blood.V116.21.1336.1336
Published: 2010
Journal Articles

Successful High-Dose Ribavirin Treatment of Respiratory Syncytial Virus-Induced Tracheobronchitis and Pneumonia Occuring Pre-Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Saskia Gueller, MD, Ulrich Duenzinger, MD, Timo Wolf, MD, Sabine Mousset, MD, Hans Martin, MD, Hubert Serve, MD, Gesine Bug, MD
Journal: Blood
Blood (2009) 114 (22): 1163.
https://doi.org/10.1182/blood.V114.22.1163.1163
Published: 2009